je.st
news
FDA Grants Orphan Drug Designation for Bayer's Investigational...
2014-04-23 11:31:27| Chemicals - Topix.net
Bayer HealthCare today announced that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted orphan drug designation for its investigational Ciprofloxacin Dry Powder for Inhalation for the treatment of non-cystic fibrosis bronchiectasis .
Tags: drug
grants
designation
fda
Category:Chemicals
Latest from this category |
All news |
||||||||||||||||||
|